2022
DOI: 10.3389/fmicb.2022.1044832
|View full text |Cite
|
Sign up to set email alerts
|

Dual roles and potential applications of exosomes in HCV infections

Abstract: The hepatitis C virus (HCV) causes severe liver diseases, including hepatitis, liver cirrhosis, and hepatocellular carcinoma, which have high morbidity and mortality. Antibody targeting receptor-mediated HCV infections have limited therapeutic benefits, suggesting that the transmission of HCV infections is possibly mediated via receptor-independent mechanisms. Exosomes are membrane-enclosed vesicles with a diameter of 30–200 nm, which originate from the fusion of endosomal multivesicular bodies with the plasma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 62 publications
0
4
0
Order By: Relevance
“…This research shows that exosomal lncRNA-RP11-583F2.2 may be used as a biomarker for the diagnosis and prognosis of HCC. Diseases associated with HCV may be diagnosed with the use of exosomes [ 148 ].…”
Section: The Role Of Exosomes In Viral Disease Diagnosismentioning
confidence: 99%
“…This research shows that exosomal lncRNA-RP11-583F2.2 may be used as a biomarker for the diagnosis and prognosis of HCC. Diseases associated with HCV may be diagnosed with the use of exosomes [ 148 ].…”
Section: The Role Of Exosomes In Viral Disease Diagnosismentioning
confidence: 99%
“…HCV-infected hepatocellular derived miRNAs (such as miR-122, let-7b and miR-206) as TLR7 ligands can induce macrophages to produce the B cell activating factor (BAFF) through exosomal delivery, while hepatocellular derived exosomal miR-122-induced BAFF can stimulate B cell proliferation and activation, meanwhile anti-HCV antibodies are produced during HCV infection ( Yin et al., 2022b ). Tlr3-activated macrophages impart anti-HCV activity to hepatocytes via exosomes containing members of the anti-HCV miRNA-29 family ( Zhou L. et al., 2022 ).…”
Section: The Role Of Exosomes In Virus Infectionmentioning
confidence: 99%
“…Recent studies have shown that HCV can spread by mechanisms that bypass the receptors. Therefore, the receptor-mediated therapeutic strategies (antibodies) have become less effective (Yin et al, 2022).…”
Section: Hepatitis Virus Infectionmentioning
confidence: 99%